Authors:
Lim, PZ
Tunis, SL
Edell, WS
Jensik, SE
Tohen, M
Citation: Pz. Lim et al., Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines, BIPOL DIS, 3(4), 2001, pp. 165-173
Authors:
Frazier, JA
Biederman, J
Tohen, M
Feldman, PD
Jacobs, TG
Toma, V
Rater, MA
Tarazi, RA
Kim, GS
Garfield, SB
Sohma, M
Gonzalez-Heydrich, J
Risser, RC
Nowlin, ZM
Citation: Ja. Frazier et al., A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder, J CH AD PSY, 11(3), 2001, pp. 239-250
Authors:
Silva, JACE
Alvarez, N
Mazzotti, G
Gattaz, WF
Ospina, J
Larach, V
Starkstein, S
Oliva, D
Cousins, L
Tohen, M
Taylor, CC
Wang, J
Tran, PV
Citation: Jace. Silva et al., Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America, J CL PSYCH, 21(4), 2001, pp. 375-381
Authors:
Meehan, K
Zhang, F
David, S
Tohen, M
Janicak, P
Small, J
Koch, K
Rizk, R
Walker, D
Tran, P
Breier, A
Citation: K. Meehan et al., A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutelyagitated patients diagnosed with bipolar mania, J CL PSYCH, 21(4), 2001, pp. 389-397
Authors:
Chengappa, KNR
Tohen, M
Levine, J
Jacobs, T
Thase, ME
Sanger, TM
Kupfer, DJ
Citation: Knr. Chengappa et al., Response to placebo among bipolar I disorder patients experiencing their first manic episode, BIPOL DIS, 2(4), 2000, pp. 332-335
Citation: Ca. Zarate et al., First-episode schizophreniform disorder: comparisons with first-episode schizophrenia, SCHIZOPHR R, 46(1), 2000, pp. 31-34
Citation: Ca. Zarate et M. Tohen, Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study, J CLIN PSY, 61(1), 2000, pp. 33-38
Authors:
Tohen, M
Strakowski, SM
Zarate, C
Hennen, J
Stoll, AL
Suppes, T
Faedda, GL
Cohen, BM
Gebre-Medhin, P
Baldessarini, RJ
Citation: M. Tohen et al., The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis, BIOL PSYCHI, 48(6), 2000, pp. 467-476
Authors:
Tohen, M
Jacobs, TG
Grundy, SL
McElroy, SL
Banov, MC
Janicak, PG
Sanger, T
Risser, R
Zhang, F
Toma, V
Francis, J
Tollefson, GD
Breier, A
Citation: M. Tohen et al., Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study, ARCH G PSYC, 57(9), 2000, pp. 841-849
Authors:
Tohen, M
Hennen, J
Zarate, CM
Baldessarini, RJ
Strakowski, SM
Stoll, AL
Faedda, GL
Suppes, T
Gebre-Medhin, P
Cohen, BM
Citation: M. Tohen et al., Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features, AM J PSYCHI, 157(2), 2000, pp. 220-228
Authors:
Zarate, CA
Tohen, M
Narendran, R
Tomassini, EC
McDonald, J
Sederer, M
Madrid, AR
Citation: Ca. Zarate et al., The adverse effect profile and efficacy of divalproex sodium compared withvalproic acid: A pharmacoepidemiology study, J CLIN PSY, 60(4), 1999, pp. 232-236
Authors:
Tohen, M
Sanger, TM
McElroy, SL
Tollefson, GD
Chengappa, R
Daniel, DG
Petty, F
Centorrino, F
Wang, R
Grundy, SL
Greaney, MG
Jacobs, TG
David, SR
Toma, V
Citation: M. Tohen et al., Olanzapine versus placebo in the treatment of acute mania, AM J PSYCHI, 156(5), 1999, pp. 702-709